Home / Intelligence / Industry Publications / Enough with data collection, FDA needs diversity policies to boost representation in clinical trials: report
Trinity’s recent white paper, titled Diversity in Clinical Trials Participation: A Life Sciences Perspective, was featured in a recent article by Fierce Biotech.
Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials
The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants? Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject-matter experts that authored Trinity Life […]
Vault Celebrates Top Employers for Diversity, Equity, and Inclusion
Trinity was featured in the Vault’s list of top employers for diversity, equity, and inclusion.
Diversity in Clinical Trials Participation: A Life Sciences Perspective
Providing optimal care to all patients is an imperative that unites the various, interconnected parts of the medical field, from primary care to the pharmaceutical industry to the work of large academic medical centers. Over the past 30 years, there have been exceptional advances in care, treatment, diagnostics, and early identification of disease. Unfortunately, even […]